Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factors are essential proteins required to initiate the translation of messenger RNA into protein in eukaryotic organisms. They regulate the recruitment and positioning of ribosomes, the initiator tRNA, and mRNA at the correct start codon, enabling the assembly of elongation-competent ribosomes and the beginning of protein synthesis. These factors are tightly regulated, often through phosphorylation and protein-protein interactions, and represent critical control points for overall gene expression. Abnormal activity or regulation of these factors is linked to diseases such as cancer and infection, and their modulation is a promising therapeutic strategy
Inhibition of cap-dependent translation initiation (anticancer/antiviral, e.g., by targeting eIF4E, eIF4A); Disruption of eIF4E/eIF4G interaction; Modulation of eIF2 phosphorylation to affect integrated stress response; Promotion or inhibition of ribosome assembly at mRNA
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor (with specific subtypes: eIF4E, eIF4G, eIF2, etc.) (eIF (for the family); commonly used forms include eIF4E, eIF4G, eIF2, eIF3, etc.).